HSA-based multi-target combination therapy: regulating drugs’ release from HSA and overcoming single drug resistance in a breast cancer model

Multi-drug delivery systems, which may be promising solution to overcome obstacles, have limited the clinical success of multi-drug combination therapies to treat cancer. To this end, we used three different anticancer agents, Cu(BpT)Br, NAMI-A, and doxorubicin (DOX), to build human serum albumin (H...

Descripción completa

Detalles Bibliográficos
Autores principales: Gou, Yi, Zhang, Zhenlei, Li, Dongyang, Zhao, Lei, Cai, Meiling, Sun, Zhewen, Li, Yongping, Zhang, Yao, Khan, Hamid, Sun, Hongbing, Wang, Tao, Liang, Hong, Yang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058715/
https://www.ncbi.nlm.nih.gov/pubmed/29350051
http://dx.doi.org/10.1080/10717544.2018.1428245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058715/
https://www.ncbi.nlm.nih.gov/pubmed/29350051
http://dx.doi.org/10.1080/10717544.2018.1428245

Ejemplares similares